Boston Scientific Corporation
BSX
Kedudukan dalam Saham
#409
Penerangan syarikat ini hanya tersedia dalam bahasa Inggeris.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Harga Saham
$41.88
Disegerakkan terakhir: 2026-10-30
Modal Pasaran
$60.69B
Perubahan (1 hari)
-1.89%
Perubahan (1 tahun)
-58.42%
Negara
US
Data saham: Financial Modeling PrepΒ·Dikemas kini Β·Bukan nasihat pelaburanΒ·Cara kami mengira
Perdagangan Boston Scientific Corporation (BSX)
Kategori
Healthcare
Hasil untuk Boston Scientific Corporation (BSX)
Hasil pada Sep 2026 TTM: $21.07B
Menurut laporan kewangan terkini daripada Boston Scientific Corporation, hasil semasa syarikat (TTM) ialah $21.07B. Pada tahun 2025, syarikat memperoleh hasil sebanyak $20.07B peningkatan berbanding hasil pada tahun 2024 iaitu $16.75B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Boston Scientific Corporation dari 2000 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Perubahan |
|---|---|---|
| 2026 (TTM) | $21.07B | 4.96% |
| 2025 | $20.07B | 19.87% |
| 2024 | $16.75B | 17.61% |
| 2023 | $14.24B | 12.29% |
| 2022 | $12.68B | 6.68% |
| 2021 | $11.89B | 19.92% |
| 2020 | $9.91B | -7.66% |
| 2019 | $10.74B | 9.28% |
| 2018 | $9.82B | 8.57% |
| 2017 | $9.05B | 7.89% |
| 2016 | $8.39B | 12.16% |
| 2015 | $7.48B | 1.31% |
| 2014 | $7.38B | 3.32% |
| 2013 | $7.14B | -1.46% |
| 2012 | $7.25B | -4.89% |
| 2011 | $7.62B | -2.36% |
| 2010 | $7.81B | -4.67% |
| 2009 | $8.19B | 1.71% |
| 2008 | $8.05B | -3.67% |
| 2007 | $8.36B | 6.85% |
| 2006 | $7.82B | 24.48% |
| 2005 | $6.28B | 11.72% |
| 2004 | $5.62B | 61.80% |
| 2003 | $3.48B | 19.08% |
| 2002 | $2.92B | 9.20% |
| 2001 | $2.67B | 0.34% |
| 2000 | $2.66B | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $48.23B | 128.91% |
US
|
|
| $37.54B | 78.19% |
IE
|
|
| $26.30B | 24.83% |
US
|
|
| $25.84B | 22.63% |
DE
|
|
| $6.51B | -69.09% |
US
|
Soalan tentang pendapatan Boston Scientific Corporation
Berapakah pendapatan Boston Scientific Corporation?
Setakat Sep 2026, pendapatan Boston Scientific Corporation bagi tempoh 12 bulan yang lalu ialah $21.07B.
Berapakah pendapatan Boston Scientific Corporation pada tahun 2025?
Pada tahun 2025, pendapatan Boston Scientific Corporation ialah $20.07B, meningkat 19.87% berbanding tahun 2024 ($16.75B).
Bagaimanakah pendapatan Boston Scientific Corporation berubah sejak tahun 2020?
Dari tahun 2020 hingga 2025, pendapatan Boston Scientific Corporation meningkat daripada $9.91B kepada $20.07B, iaitu pertumbuhan purata 15.16% setahun.
Bagaimanakah pendapatan Boston Scientific Corporation berbanding syarikat yang serupa?
Dengan nilai $21.07B, pendapatan Boston Scientific Corporation lebih tinggi berbanding 1 daripada 5 syarikat serupa yang disenaraikan di atas. Yang tertinggi dalam kalangan syarikat tersebut ialah Abbott Laboratories, dengan $48.23B.